Data as of Oct 22
| +0.13 / +7.83%|
The 1 analysts offering 12-month price forecasts for CorMedix Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +67.60% increase from the last price of 1.79.
The current consensus among 1 polled investment analysts is to Buy stock in CorMedix Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.